Want to see IN:INDRAMEDCO full AI Analyst Report?
Top Page
Indraprastha Medical Corporation Limited
(INDRAMEDCO)
Select Model
Select Model
Rating:71Outperform
Price Target:
₹413.00
▼(-9.44% Downside)
Action:Reiterated
Date:08/17/26
The score is primarily supported by strong financial performance: improved profitability, solid cash generation, and a very low-leverage balance sheet. Offsetting this, technical signals are weak-to-neutral with the stock trading below key longer-term moving averages and a slightly negative MACD. Valuation is broadly reasonable (moderate P/E with a modest dividend yield), neither a strong tailwind nor a major headwind.
Positive Factors
Revenue Growth
The multi-year revenue increase indicates sustained expansion in hospital services and patient activity. Positive growth in each of the last five years supports the durability of the operating model, although the latest annual growth rate moderated.
Negative Factors
Slowing Revenue Growth
Although revenue has grown consistently over several years, the latest slowdown suggests the company may be approaching a more mature growth phase or facing capacity, pricing, or volume constraints. Sustained deceleration could limit future operating leverage and earnings expansion.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
The multi-year revenue increase indicates sustained expansion in hospital services and patient activity. Positive growth in each of the last five years supports the durability of the operating model, although the latest annual growth rate moderated.
Read all positive factors
Indraprastha Medical Corporation Limited (INDRAMEDCO) vs. iShares MSCI India ETF (INDA)
Market Cap
₹32.10B
Dividend Yield1.28%
Average Volume (3M)24.57K
Price to Earnings (P/E)17.1
Beta (1Y)1.56
Revenue Growth10.92%
EPS Growth12.12%
CountryIN
Employees3,035
SectorGeneral
Sector StrengthN/A
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)20.51
Shares Outstanding91,673,000
10 Day Avg. Volume9,986
30 Day Avg. Volume24,575
Financial Highlights & Ratios
PEG Ratio1.32
Price to Book (P/B)4.61
Price to Sales (P/S)2.30
P/FCF Ratio26.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)22.6
Revenue Forecast (FY)₹15.77B
Indraprastha Medical Corporation Limited Business Overview & Revenue Model
Company Description
Indraprastha Medical Corporation Limited (IMCL) is a prominent Indian healthcare provider, delivering a broad spectrum of hospital services across the nation. The company offers comprehensive medical and surgical solutions across an extensive rang...
How the Company Makes Money
INDRAMEDCO generates revenue primarily by delivering hospital services to patients at its facility. Key revenue streams typically include: (1) Inpatient services (room/bed charges, nursing and care services, intensive care, in-hospital procedures,...
Indraprastha Medical Corporation Limited Financial Statement Overview
Summary
Income Statement
82
Very Positive
Balance Sheet
88
Very Positive
Cash Flow
79
Positive
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.24B | 14.83B | 13.56B | 12.45B | 10.99B | 8.88B |
| Gross Profit | 5.16B | 5.06B | 3.50B | 3.13B | 6.25B | 4.79B |
| EBITDA | 2.95B | 2.96B | 2.44B | 2.07B | 1.61B | 1.17B |
| Net Income | 1.88B | 1.84B | 1.61B | 1.24B | 861.50M | 586.20M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 9.91B | 8.52B | 7.23B | 5.55B | 4.62B |
| Cash, Cash Equivalents and Short-Term Investments | 2.63B | 2.63B | 3.19B | 2.24B | 1.36B | 660.10M |
| Total Debt | 0.00 | 368.60M | 327.60M | 339.50M | 24.80M | 53.10M |
| Total Liabilities | -7.40B | 2.51B | 2.55B | 2.45B | 1.76B | 1.36B |
| Stockholders Equity | 7.40B | 7.40B | 5.97B | 4.78B | 3.79B | 3.25B |
Cash Flow | ||||||
| Free Cash Flow | 808.10M | 1.30B | 1.20B | 1.31B | 998.90M | 418.10M |
| Operating Cash Flow | 935.10M | 1.89B | 1.57B | 2.00B | 1.44B | 712.90M |
| Investing Cash Flow | -1.47B | -2.02B | -1.11B | -1.58B | -1.08B | -511.00M |
| Financing Cash Flow | -56.60M | -434.60M | -458.80M | -323.80M | -260.40M | -33.70M |
Indraprastha Medical Corporation Limited Technical Analysis
Negative
456.05
Price Trends
372.20
Negative
382.75
Negative
406.39
Negative
Market Momentum
-5.04
Positive
34.22
Neutral
13.41
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INDRAMEDCO, the sentiment is Negative. The current price of 456.05 is above the 20-day moving average (MA) of 369.35, above the 50-day MA of 372.20, and above the 200-day MA of 406.39, indicating a bearish trend. The MACD of -5.04 indicates Positive momentum. The RSI at 34.22 is Neutral, neither overbought nor oversold. The STOCH value of 13.41 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:INDRAMEDCO.
Indraprastha Medical Corporation Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | ₹52.67B | 43.58 | ― | 0.13% | 14.96% | 20.76% | |
71 Outperform | ₹32.10B | 17.06 | ― | 1.14% | 10.92% | 12.12% | |
70 Outperform | ₹394.93B | 71.40 | ― | 0.07% | 21.27% | 4.09% | |
62 Neutral | ₹1.25T | 59.52 | ― | 0.23% | 17.20% | 32.79% | |
60 Neutral | ₹687.01B | 65.20 | ― | 0.11% | 17.50% | 20.65% | |
55 Neutral | ₹958.68B | 65.78 | ― | 0.20% | 15.96% | 26.87% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
* General Sector Average
IN:INDRAMEDCO
Indraprastha Medical Corporation Limited
351.65
-120.54
-25.53%
IN:APOLLOHOSP
Apollo Hospitals Enterprise Limited
8,760.00
994.72
12.81%
IN:ARTEMISMED
Artemis Medicare Services Ltd.
343.85
108.95
46.38%
IN:FORTIS
Fortis Healthcare Ltd.
908.00
-33.70
-3.58%
IN:MAXHEALTH
Max Healthcare Institute Ltd
990.70
-156.86
-13.67%
IN:MEDANTA
Global Health Limited
1,421.95
29.89
2.15%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.